Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Interim Management Statement

16 Nov 2009 13:19

RNS Number : 5697C
British SmallerTechCompaniesVCT2PLC
16 November 2009
 



BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 30 September 2009. This constitutes the Company's second interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 30 September 2009 was 73.0p (30 June 200975.7p). The net asset value as at 30 September 2009 is stated after taking account of the interim dividend of 2.0p per Ordinary share and the special dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2009. These dividends were paid on 2 October 2009 and 30 October 2009 respectively.

The total return at 30 September 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, increased to 95.0p per share from 93.7p at 30 June 2009.

The number of Ordinary shares in issue at 30 September 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 30 September 2009 comprised the following:

£000

% of net assets

Unquoted investments at fair value

4,677

38.5%

Quoted investments at bid price

1,023

8.4%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Cash and cash equivalents

1,986

16.3%

Other net current assets (liabilities)

570

4.7%

Net assets

12,154

100.0%

The ten largest investments by valuation at 30 September 2009 were as follows:

£000

% of net assets

Digital Healthcare Limited

1,659

13.6%

Immunobiology Limited

807

6.6%

Primal Pictures Limited

742

6.1%

Pressure Technologies plc

440

3.6%

Silistix Limited

387

3.2%

Waterfall Services Limited

382

3.2%

Harvey Jones Limited

273

2.3%

Patsystems plc

258

2.1%

Ellfin Home Care Limited

150

1.2%

RMS Group Holdings Limited

146

1.2%

Top ten investments

5,244

43.1%

Other investments

456

3.8%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Quoted investments are carried at bid price at 30 September 2009. Unquoted investment are carried at fair value as at 30 September 2009 as determined by the directors.

During the three months ended 30 September 2009 the following significant investment transactions took place (all companies are unquoted except where otherwise indicated):

Disposals

Name of company:

Sale proceeds

£000

Original 

cost

£000

Carrying value at 

30 June 2009

£000

DxS 

1,755*

163

817

ART Technology Group (AiM)

567

244

519

Oxonica (AiM)

3

62

6

RMS Group Holdings 

3

3

3

2,328

472

1,345

* excluding deferred proceeds of £214,000

Performance 

In this period the Company has seen its underlying net asset value decrease by 2.7p per share after the payment of an interim dividend of 2.0p per Ordinary share and a special dividend of 2.0p per Ordinary share. 

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 1.3p to 95.0p per share, cumulative dividends representing 22.0p per share.

The net asset value currently comprises 48% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

The net asset value per share remains significantly in excess of the current share price.

Outlook 

Whilst there remains uncertainty over the speed of recovery in the markets the last quarter has demonstrated that positive realisations are still possible for the right quality of investments. There is some evidence of an increasing search for capital from businesses seeking to expand which your Board believes will translate into increasing investment opportunities over both the short and medium term. This Company is well placed to continue to support these investments and take advantage of investment opportunities that may arise in the short term and is intending to ensure it has sufficient capacity to meet future investment demand. 

16 November 2009

For further information please contact:

David Hall  YFM Private Equity Tel: 0161 832 7603

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGMGGUPBGWQ
Date   Source Headline
18th Dec 201410:00 amRNSCompletion of New Investment
8th Dec 20141:07 pmRNSTransaction in Own Shares
3rd Dec 201412:54 pmRNSResult of General Meeting
3rd Dec 20149:23 amRNSCompletion of New Investments
20th Nov 201410:57 amRNSInterim Statement & Change of Company Secretary
27th Oct 20144:40 pmRNSCompletion of two new investments
20th Oct 20145:00 pmRNSPublication of Prospectus and Circular re: offers
10th Oct 201412:43 pmRNSDirector Declaration
7th Oct 20145:10 pmRNSPayment of Dividend and Allotment of Share
15th Aug 201411:47 amRNSHalf Yearly Report
18th Jul 201411:27 amRNSIssue of Equity - Replacement
30th Jun 20144:16 pmRNSIssue of Equity
27th Jun 20144:36 pmRNSTransaction in Own Shares
30th May 20147:00 amRNSOffers for Subscription: Allotment of Shares
28th May 20144:46 pmRNSDividend Payment Date
19th May 20142:21 pmRNSInterim Management Statement to 31 March 2014
19th May 201412:52 pmRNSResult of Annual General Meeting
29th Apr 20147:00 amRNSPostponement of Allotment and Dividend
10th Apr 20145:50 pmRNSJoint Offers - Supplementary Prospectus
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 201410:15 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
7th Apr 20147:00 amRNSOffers for Subscription: Allotment of Shares
1st Apr 20145:25 pmRNSOffers for Subscription: Allotment of Shares
28th Mar 20144:13 pmRNSAnnual Financial Report
18th Feb 20145:30 pmRNSResult of General Meeting
15th Jan 20147:30 amRNSPublication of Prospectus re: joint offer
31st Oct 20137:15 amRNSTransaction in Own Shares
25th Oct 20137:00 amRNSInterim Management Statement to 30 September 2013
30th Sep 20135:30 pmRNSManagement Arrangements
27th Sep 201311:02 amRNSIssue of Equity and Dividend Paid
23rd Sep 20135:17 pmRNSStatement re Proposed Joint Fundraising
21st Aug 20131:48 pmRNSHalf Yearly Report to 30 June 2013
19th Jun 20134:34 pmRNSTransaction in Own Shares
5th Jun 201311:04 amRNSIssue of Equity
20th May 20131:35 pmRNSResult of AGM
1st May 20137:00 amRNSIssue of Equity
30th Apr 201312:24 pmRNS1st Quarter - Interim Management Statement
19th Apr 20137:00 amRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity
4th Apr 201311:20 amRNSIncrease of Offer Size
2nd Apr 20137:00 amRNSAnnual Financial Report
31st Dec 201211:27 amRNSAllotment of Shares
18th Dec 20123:30 pmRNSResult of General Meeting
22nd Nov 20127:00 amRNSTransaction in Own Shares
19th Nov 201212:26 pmRNSPublication of Prospectus and Circulars re Offer
13th Nov 20122:27 pmRNSInterim Management Statement
26th Oct 20122:06 pmRNSIssue of Equity
1st Oct 201210:03 amRNSStatement re Proposed Joint Fundraising
29th Aug 201211:17 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.